Microbiome Diagnostics for Early Locomotor Condition Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for characterizing the human microbiome and providing personalized therapeutic measures for locomotor system conditions are limited due to inadequate sample processing techniques and data analysis, leaving many questions unanswered regarding health conditions and therapies.
Innovation Solution
A method and system for characterizing the microbiome composition and functional features of a population, generating datasets, and transforming these into models to diagnose and suggest therapies for locomotor system conditions, including probiotic, phage-based, and small-molecule-based interventions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional biomarker testing methods are used, then existing diagnostic capabilities are maintained, but they fail to detect early-stage locomotor conditions and provide limited actionable insights
Solution Approach 1:
The patent applies universality by developing a multi-omics platform that simultaneously performs multiple diagnostic functions including detecting early-stage locomotor conditions, identifying disease progression, predicting treatment response, and monitoring therapeutic outcomes. The system integrates genomics, transcriptomics, proteomics, and metabolomics data to provide comprehensive diagnostic capabilities beyond what single-marker tests can achieve.
Solution Approach 2:
The patent applies segmentation by dividing the diagnostic process into distinct functional modules: sample collection, multi-omics analysis, machine learning-based interpretation, and clinical decision support. This segmented approach allows each component to be optimized independently while maintaining high detection sensitivity across different disease stages and types.
2Reliability
If comprehensive multi-omics analysis is implemented, then diagnostic accuracy and early detection capability are improved, but system complexity and implementation difficulty increase
Solution Approach 1:
The patent applies the intermediary principle by introducing machine learning algorithms and clinical decision support systems that act as intermediaries between the complex multi-omics data and clinical interpretation. These computational tools automatically integrate genomics, transcriptomics, proteomics, and metabolomics data, reducing the burden on clinicians while maintaining high diagnostic accuracy.
Solution Approach 2:
The patent replaces manual diagnostic processes with automated computational systems. Machine learning models automatically analyze multi-omics datasets, identify patterns, and generate diagnostic recommendations, substituting the mechanical manual review process with intelligent automated systems that handle complexity while improving reliability.
3Ease of operation
If microbiome-based diagnostics are used, then non-invasive sampling and patient comfort are improved, but diagnostic precision for specific locomotor conditions may be reduced
Solution Approach 1:
The patent applies composite materials by combining multiple types of biological information (genomics, transcriptomics, proteomics, metabolomics, and microbiome data) into a composite diagnostic profile. This multi-layered approach compensates for the limitations of non-invasive microbiome sampling alone, maintaining high diagnostic precision through data fusion from multiple sources.
Solution Approach 2:
The patent merges microbiome analysis with other omics data types to create an integrated diagnostic system. By combining gut microbiome, oral microbiome, and host genomic/proteomic/metabolomic data, the system achieves both the sampling convenience of non-invasive microbiome collection and the diagnostic precision of comprehensive multi-omics analysis.
Data Source
Figure 1A~1B
Figure 2
Figure 3
AI summary
A method for at least one of characterizing, diagnosing, and treating a locomotor system condition in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the locomotor system condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the locomotor system condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.